Parenteral Nutrition Clinical Trial
Official title:
A Prospective, Randomized, Controlled, Double-blind, Crossover-Design, Mono-center, Phase IV Study Comparing the Effect of Omegaven in Combination With Clinoleic or Lipoplus or SMOFlipid in Home Parenteral Nutrition Patients
The aim of this study was to evaluate the safety and tolerance of ClinOleic or Lipoplus or SMOFlipid lipid emulsions. After 6 weeks of each lipid emulsion, Omegaven (fish oil) was added for a further 4 weeks. The safety and tolerance was evaluated after each lipid emulsion cycle by biochemistry, hematology and coagulation variables, vital signs and adverse events. We also analysed fatty acid profiles in plasma or erythrocyte phospholipids, antioxidant enzyme activities, lipid peroxidation products, plasma lipids and pro-inflammatory cytokine production after in vitro stimulation of whole blood by lipopolysacharide in HPN patients. The non-interventional group of healthy controls was included for comparison.
Intravenous lipid emulsions (LEs) are an indispensable part of home parenteral nutrition (HPN). All commercially obtainable LEs are applicable for HPN in providing a source of energy and essential fatty acids. The originally used soyabean oil-based LE (Intralipid) have been suspected of being associated with a higher risk of pro-inflammatory lipid-mediator production due to their high content of n-6 polyunsaturated fatty acids. The more modern mixes of soyabean oil, and/or olive oil, and/or fish oil LEs with beneficial responses compared with Intralipid are available. Given that there are no clear clinical recommendations for LE application in HPN, we performed this cross-over design, phase 4 study comparing ClinOleic, Lipoplus or SMOFlipid in chronic intestinal failure patients with additional escalation of fish oil using Omegaven. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03606863 -
Peripheral Parenteral Nutrition vs Conventional Fluid in Colorectal Resection in ERAS
|
Phase 3 | |
Completed |
NCT00451646 -
Study Comparing the Safety and Tolerance of SMOFlipid 20% in Long-term Treatment With Parenteral Nutrition
|
Phase 3 | |
Completed |
NCT04006730 -
Analysis of the Pharmaceutical Validation of Picc Line Installation Requests at the Nîmes University Hospital
|
||
Enrolling by invitation |
NCT06161350 -
The Multi-disciplinary Approach of Children With Feeding Difficulties and Tube Feeding in UZB Between 2000 and 2021
|
||
Completed |
NCT04234152 -
Complete Shielding of Multivitamins to Reduce Toxic Peroxides in the Parenteral Nutrition: A Pilot Study
|
N/A | |
Completed |
NCT00672854 -
Study Comparing a Soybean Oil-Based With an Olive Oil-Based Lipid Emulsion in ICU Patients Requiring TPN
|
Phase 2/Phase 3 | |
Active, not recruiting |
NCT01839617 -
Study Comparing Early and Late Nutrition in Cancer Patients Undergoing Abdominal Surgery
|
N/A | |
Completed |
NCT05299099 -
Clinical Trial to Evaluate the Safety and Efficacy of IN-C006 Inj. Compared With RCN301
|
Phase 3 | |
Withdrawn |
NCT02463812 -
Lipid Infusion Following Major Surgery
|
N/A | |
Completed |
NCT04816734 -
Initial Parenteral Nutrition Education of Parent Assessment Plan
|
N/A | |
Terminated |
NCT01814956 -
Different Lipid Emulsions in Acute Lung Injury Patients
|
Phase 4 | |
Completed |
NCT04234490 -
Longitudinal Evaluation of the Impact of Parenteral Nutrition
|
||
Recruiting |
NCT05519761 -
A Retrospective, Observational, Multicenter Study to Evaluate the Safety and Performance of POLYSITE® and SEESITE® Implantable Ports
|
||
Completed |
NCT00321165 -
The AOT (Acridine Orange and Taurolidine) Trial
|
Phase 3 | |
Completed |
NCT00292279 -
The Impact of Omega-3 Fat Emulsion on Clinical Outcome of Post-Operative Cancer Patients
|
Phase 3 | |
Recruiting |
NCT03157245 -
Incidence of Deep Vein Thrombosis on Central Venous Catheters in the Post Operative Period of Carcinologic Surgery
|
N/A | |
Recruiting |
NCT03693287 -
Personalized vs Standardized PN for Preterm Infants >1250g
|
Phase 4 | |
Completed |
NCT02828150 -
Integrative Parenteral Nutrition in Cancer Patients
|
N/A | |
Completed |
NCT00798681 -
Evaluating the Influence of Ready-to-use (RTU) Parenteral Nutrition in the Clinical Outcome of Patients Study
|
Phase 4 | |
Completed |
NCT00512629 -
Cholestasis Prevention: Efficacy of IV Fish Oil
|
Phase 1 |